Objective Life-threatening ventricular arrhythmias are recognized in patients with coronary spastic angina. Implantable cardioverter-defibrillators (ICDs) are effective in patients with structural heart disease and ventricular fibrillation. However, the optimal medication for patients with aborted sudden cardiac death (SCD) due to coronary artery spasm after the implantation of ICD remains controversial. Methods We investigated the medications and the numbers of appropriate ICD shocks in 137 patients with a history of aborted SCD due to coronary spasm. Results Appropriate ICD shocks were observed in 24.1% (33/137) of patients with aborted SCD due to coronary spasm during 41 months of follow-up. Only 15 (15.6%) of the 96 patients with ICDs received aggressive medical therapy, including two or three calcium-channel antagonists. The rate of appropriate ICD shocks was significantly higher in Western countries than in Asian countries (42.9% vs. 19.3%, p<0.01), whereas the medications did not differ between the two regions. Appropriate ICD shocks successfully resuscitated 33 patients. Three patients died due to second serious fatal arrhythmias. Conclusion Appropriate ICD shocks were recognized in a quarter of patients with aborted SCD due to coronary spasm and ICD implantation was effective for suppressing the next serious fatal arrhythmia in these patients. We should reconsider prescribing more medications after ICD implantation in patients with aborted SCD due to coronary artery spasm.
Introduction
Life-threatening ventricular arrhythmias after resuscitation from aborted sudden cardiac death (SCD) in patients with coronary artery spasm are a major problem in the clinical setting (1) . Under optimal medical therapy, including calcium-channel antagonists or nitrates, in the majority of cases, coronary spastic angina shows a good clinical course, whereas patients with aborted SCD due to coronary artery spasm may have a poor prognosis (2) (3) (4) (5) (6) . Implantable cardioverter-defibrillators (ICDs) have been effective in patients with structural heart disease and ventricular fibrillation (7) . The majority of the clinical reports published in the recent era concluded that ICDs were useful in patients with aborted SCD due to coronary artery spasm (8) (9) (10) (11) . However, although these patients received optimal medical therapy, we had no data about the appropriate ICD shocks that were administered to patients with aborted SCD due to coronary spasm after ICD implantation. We analyzed the past reports about appropriate ICD shocks and the medications that were administered after ICD implantation in patients with aborted SCD due to coronary artery spasm. We also compared the rates of appropriate ICD shocks and medications in patients from Western and Asian countries. 
Materials and Methods

Study subjects
We extracted the papers published about ICD implantation in patients with coronary spastic angina from the PubMed database. We were able to analyze 137 patients who underwent the implantation of an ICD after the aborted SCD due to coronary artery spasm. Among the 137 patients, one patient had coronary artery spasm and Burgada syndrome, another patient had cocaine-induced spasm and one underwent ICD implantation after the implantation of a sirolimuseluting stent (Cypher). We investigated the frequency of appropriate ICD shocks and compared the coronary risk factors, arteries with proven spasm, the medications and the prognosis after the implantation of ICD between patients with and without appropriate ICD shocks. Moreover, we compared Western and Asian patients with aborted SCD due to coronary artery spasm after ICD implantation, because coronary artery spasm has been reported to occur more frequently in Asian countries than in Western countries.
Statistical analysis
All of the data were presented as the mean±1 standard deviation (SD). All of the categorical variables were analyzed by Fisher's exact test with correction or by the MannWhitney U test. p values of <0.05 were considered to indicate statistical significance.
Results
Appropriate ICD shocks
As shown in Table 1 , 137 patients underwent ICD implantation after aborted SCD due to coronary artery spasm . During the follow-up period (41±28 months), appropriate ICD shocks were observed in 33 patients 
Coronary risk factors
As shown in Table 2 , we could only analyze the coronary risk factors in 43 (31.4%) patients; the records of the remaining 94 patients were missing data about coronary risk factors. Appropriate ICD shocks were observed in 7 (16.3%) of 43 patients, while the remaining 36 patients (83.7%) received no ICD shocks. The rates of male sex and a history of smoking in patients without appropriate ICD shocks were significantly higher than in those with appropriate ICD shocks.
Provable artery spasm
We could only analyze the 63 (45.6%) cases involving provable artery spasm. These included 24 Table 3 shows the medications in 33 patients with appropriate ICD shocks. We could not analyze the medications in 11 patients (33.3%) because of missing data. Only 5 patients (15.2%) received 2 or 3 calcium-channel antagonists, while 17 patients (51.5%) had were treated with a single calciumchannel antagonist. Nitrates or nicorandils were administered to 13 patients (39.4%). Only one patient (3%) was treated with triple calcium-channel antagonists. Seven patients (31.8%) were treated with 1 vasodilator, 10 (45.5%) patients were treated with 2 vasodilators and 5 (22.7%) patients were treated with 3 vasodilators. Table 4 shows the medications that were administered to 104 patients without appropriate ICD shocks. Two or three calcium-channel antagonists were administered to just 10 patients (9.6%), whereas 62 patients (59.6%) were treated with a single calcium-channel antagonist. Nitrates or nicorandils were administered to 55 patients (52.9%). No patients were treated with triple calcium-channel antagonists. Detailed medication information was not available for 30 patients (28.9%). Twelve patients (16.2%) were treated with one vasodilator, while 39 (52.7%) patients received 2 vasodilators or 14 (18.9%) patients received 3 vasodilators. Moreover, 2 (2.7%) patients received no medications, while 3 (4.1%) patients were treated with four vasodilators.
Medications in patients with appropriate ICD shocks
The medications in patients without appropriate ICD shocks
The medications and appropriate ICD shocks in patients from Western and Asian countries
The rate of appropriate ICD shocks was significantly Intern Med 57: 1361-1369, 2018 DOI: 10.2169/internalmedicine.8796-17 Fig. 1 . However, the medications that were administered after the implantation of an ICD in patients with aborted SCD due to coronary spasm did not differ between patients from Western and Asian countries.
The medications administered to patients with and without appropriate ICD shocks
As shown in Table 5 , the medications in patients with appropriate ICD shocks did not differ from those in patients without appropriate ICD shocks. One calcium-channel antagonist was administered to 77.3% of the patients with appropriate ICD shocks, whereas 83.8% of the patients without appropriate ICD shocks were treated with 1 calciumchannel antagonist. In contrast, more than 3 vasodilators were administered to 22.7% of the patients with appropriate ICD shocks, while 24.3% of the patients without appropriate ICD shocks were treated with three or four vasodilators. We could only analyze the dosage of calcium-channel antagonists and nitrates/nicorandils in 45 (32.8%) patients (Table 6). Diltiazem and nicorandil were often administered to patients in Asian countries, while verapamil was most frequently administered in Western countries. However, with the exception of diltiazem, the dosages did not differ between the two countries. Eight patients were treated with amiodarone, including one patient with appropriate ICD shock.
The prognosis after the appropriate ICD shocks
Appropriate ICD shocks were effective in suppressing ventricular tachycardia in 3 patients, ventricular tachycardia or fibrillation in 9 patients and ventricular fibrillation in 21 patients. Three patients with aborted SCD due to coronary spasm, who had undergone the implantation of an ICD, died during the follow-up period. One patient died due to pulseless electrical activity despite the continuous delivery of electrical therapy by the ICD, the second patient died due to intractable ventricular fibrillation, and the third patient died due to electromechanical dissociation and severely reduced left ventricular contraction despite appropriate ICD therapy. With the exception of the 3 patients who died, all 33 who received appropriate ICD shocks were rescued from second ventricular fibrillation/tachycardia. As shown in Fig. 2, 8 patients each from Western and Asian countries received appropriate ICD shocks. Within 12 months, appropriate ICD shocks were recognized in 10 (62.5%) of 16 patients. The details of the periods in which the appropriate ICD shocks were delivered were not found in 17 patients.
Discussion
During the 41-month follow-up period, appropriate ICD shocks were recognized in 24.1% of the patients with (1) counterparts. The incidence of ventricular tachycardia or ventricular fibrillation during pharmacological spasm provocation tests in Asian countries was significantly higher than in Western countries, whereas the rates of cardiogenic shock, acute coronary syndrome and death in Asian countries were remarkably lower in comparison to Western countries (42). The incidence of coronary artery spasm was three times higher in Asian countries than in Western countries. We had no data about the precise frequency of ICD implantation in patients with aborted SCD due to coronary spasm in Western and Asian countries. Although the medications after ICD implantation did not differ between Western and Asian countries, the rate of appropriate ICD shocks in patients in Western countries was significantly higher in comparison to those in Asian countries. We did not understand the reasons for the higher incidence of appropriate ICD shocks in Western countries. However, these patients might have higher disease activity than Asian patients. Actually, angiographic spontaneous spasm was more often observed in Western countries than in Asian countries. According to the Japanese Circulation Society (JCS) guidelines for the non-pharmacotherapy of cardiac arrhythmia (43), ICD implantation was defined as class IIb when patients were at high risk of next fatal arrhythmia, such as ventricular fibrillation or tachycardia due to coronary spasm, irrespective of whether they received appropriate medical therapy. Medical therapy is the first-line treatment for patients with aborted SCD due to coronary spasm. In the clinic, we had no precise strategy for ICD implantation in patients with aborted SCD due to coronary vasospasm. Eschalier et al. reported the clinical use of ergonovine tests under the optimal medications when cardiologists considered the necessity of ICD implantation in patients with aborted SCD due to coronary spasm (32) . We also reported the results of pharmacological spasm provocation testing under patients with refractory spasm who were treated with medical therapy (44) . ICD implantation may not be always necessary for patients with aborted SCD who had lifethreatening ventricular arrhythmia and coronary spasm. Actually, in this short article, appropriate ICD shocks were not recognized in three quarters of the patients. Pharmacological spasm provocation tests in patients receiving appropriate medical therapy may become a clinical tool that can be used to differentiate patients with aborted SCD due to coronary spasm require ICD implantation. However, at present, we are of the opinion that ICD implantation in patients with aborted SCD due to coronary spasm may be adequate for classifying a patient as class IIb, because we had no prospective data about the appropriate ICD shocks that were delivered in these patients.
Limitations
The present study was associated with some limitations. First was a retrospective study. Moreover, there were selection and publication biases in the published papers. Second, the same categorical data were not available to compare each of the issues in all of the 137 patients. We were able to analyze the dosage of calcium channel antagonists or nitrate/ nicorandil and coronary risk factors in less than a third of the patients. We tried to analyze these data using a multivariate regression analysis. However, we could not obtain statistically significant results due to the data that were missing in each paper. Further prospective studies will be necessary to investigate the optimal treatments for suppressing the next serious fatal arrhythmia after ICD implantation in patients with aborted SCD due to coronary spasm.
Conclusions
After ICD implantation in patients with aborted SCD due to coronary artery spasm, appropriate ICD shocks were observed in a quarter of these patients during the 41-month follow-up period. Cardiologists should reconsider administering more medications, including two or three calcium channel antagonists, to patients with aborted SCD due to coronary artery spasm as well as ICD implantation.
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